2020
DOI: 10.1016/j.ejphar.2020.173278
|View full text |Cite
|
Sign up to set email alerts
|

2-Methoxyestradiol ameliorates metabolic syndrome-induced hypertension and catechol-O-methyltransferase inhibited expression and activity in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…It possesses pleotropic pharmacological actions. These include anticancer [ 20 ], antihypertensive [ 21 , 22 ], vascular-protective [ 23 ], and neuroprotective [ 24 ] activities. 2-Methoxyestradiol was shown to prevent kidney damage and improves survival in septic mice via inhibiting the production of cytokines and nitric oxide [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…It possesses pleotropic pharmacological actions. These include anticancer [ 20 ], antihypertensive [ 21 , 22 ], vascular-protective [ 23 ], and neuroprotective [ 24 ] activities. 2-Methoxyestradiol was shown to prevent kidney damage and improves survival in septic mice via inhibiting the production of cytokines and nitric oxide [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…9 In addition, treatment with 2-ME protects against development of hypertension in Ang II–induced hypertension and in metabolic syndrome–associated hypertension. 10,11 In addition, growing evidence indicates that COMT-deficient mice have a preeclampsia-like phenotype, with hypertension developing on day 17 of pregnancy. 12 Clinical studies also suggest that COMT is downregulated in patients with preeclampsia, since levels of COMT and 2-ME are significantly lower in placentas from preeclamptic patients compared with normotensive counterparts.…”
mentioning
confidence: 99%